Welcome to the real world Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
Leading by example Wednesday, December 01, 2004
Working with key opinion leaders to promote new products is an important part of the pharma marketing mix, but a changing environment requires a new approach....(more)
Breaking through the glass ceiling Wednesday, December 01, 2004
Boardrooms have traditionally been male dominated but the tide is slowly starting to change with the fairer sex making strong progress in the pharma industry....(more)
